Literature DB >> 20598238

Differential effects of serotonergic and noradrenergic antidepressants on brain activity during a cognitive control task and neurofunctional prediction of treatment outcome in patients with depression.

Gerd Wagner1, Kathrin Koch, Claudia Schachtzabel, Thomas Sobanski, Jürgen R Reichenbach, Heinrich Sauer, Ralf G M Schlösser.   

Abstract

BACKGROUND: We investigated the differential effects of serotonergic and noradrenergic antidepressants on brain activation in patients with major depressive disorder during a Stroop task. We predicted that pretreatment hyperactivity in the rostral anterior cingulate cortex would predict better treatment outcomes.
METHODS: In total, 20 patients underwent naturalistic open-label clinical treatment with citalopram (n = 12) or reboxetine (n = 8). We performed functional magnetic resonance imaging at baseline and after 6 weeks of treatment.
RESULTS: There were no significant group differences in clinical characteristics, treatment outcomes or baseline fMRI activations. The group by time interaction revealed significant voxels in the right amygdala-hippocampus complex (p < 0.05, family-wise error corrected by use of the bilateral amygdala and hippocampus mask image as a small volume), indicating a posttreatment blood oxygen level- dependent signal decrease in the citalopram group. Pretreatment hyperactivity in the rostral anterior cingulate cortex was not related to symptom improvement. LIMITATIONS: Our study was a nonrandomized clinical trial.
CONCLUSION: These results indicate that serotonergic and noradrenergic antidepressants have a differential effect on brain activity, especially in the amygdala and hippocampus.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20598238      PMCID: PMC2895155          DOI: 10.1503/jpn.090081

Source DB:  PubMed          Journal:  J Psychiatry Neurosci        ISSN: 1180-4882            Impact factor:   6.186


  36 in total

1.  Increased amygdala response to masked emotional faces in depressed subjects resolves with antidepressant treatment: an fMRI study.

Authors:  Y I Sheline; D M Barch; J M Donnelly; J M Ollinger; A Z Snyder; M A Mintun
Journal:  Biol Psychiatry       Date:  2001-11-01       Impact factor: 13.382

2.  Functional anatomical correlates of antidepressant drug treatment assessed using PET measures of regional glucose metabolism.

Authors:  Wayne C Drevets; Wendy Bogers; Marcus E Raichle
Journal:  Eur Neuropsychopharmacol       Date:  2002-12       Impact factor: 4.600

Review 3.  The cellular neurobiology of depression.

Authors:  H K Manji; W C Drevets; D S Charney
Journal:  Nat Med       Date:  2001-05       Impact factor: 53.440

4.  Brain metabolic changes in major depressive disorder from pre- to post-treatment with paroxetine.

Authors:  A L Brody; S Saxena; D H Silverman; S Alborzian; L A Fairbanks; M E Phelps; S C Huang; H M Wu; K Maidment; L R Baxter
Journal:  Psychiatry Res       Date:  1999-10-11       Impact factor: 3.222

5.  Anterior cingulate activity as a predictor of degree of treatment response in major depression: evidence from brain electrical tomography analysis.

Authors:  D Pizzagalli; R D Pascual-Marqui; J B Nitschke; T R Oakes; C L Larson; H C Abercrombie; S M Schaefer; J V Koger; R M Benca; R J Davidson
Journal:  Am J Psychiatry       Date:  2001-03       Impact factor: 18.112

6.  Regional metabolic effects of fluoxetine in major depression: serial changes and relationship to clinical response.

Authors:  H S Mayberg; S K Brannan; J L Tekell; J A Silva; R K Mahurin; S McGinnis; P A Jerabek
Journal:  Biol Psychiatry       Date:  2000-10-15       Impact factor: 13.382

7.  Changes in regional brain glucose metabolism measured with positron emission tomography after paroxetine treatment of major depression.

Authors:  S H Kennedy; K R Evans; S Krüger; H S Mayberg; J H Meyer; S McCann; A I Arifuzzman; S Houle; F J Vaccarino
Journal:  Am J Psychiatry       Date:  2001-06       Impact factor: 18.112

Review 8.  Comparative efficacy and acceptability of 12 new-generation antidepressants: a multiple-treatments meta-analysis.

Authors:  Andrea Cipriani; Toshiaki A Furukawa; Georgia Salanti; John R Geddes; Julian Pt Higgins; Rachel Churchill; Norio Watanabe; Atsuo Nakagawa; Ichiro M Omori; Hugh McGuire; Michele Tansella; Corrado Barbui
Journal:  Lancet       Date:  2009-02-28       Impact factor: 79.321

9.  Inhibitory effect of hippocampal 5-HT1A receptors on human explicit memory.

Authors:  Fumihiko Yasuno; Tetsuya Suhara; Takashi Nakayama; Tetsuya Ichimiya; Yoshiro Okubo; Akihiro Takano; Tomomichi Ando; Makoto Inoue; Jun Maeda; Kazutoshi Suzuki
Journal:  Am J Psychiatry       Date:  2003-02       Impact factor: 18.112

10.  The neural substrates of affective processing in depressed patients treated with venlafaxine.

Authors:  Richard J Davidson; William Irwin; Michael J Anderle; Ned H Kalin
Journal:  Am J Psychiatry       Date:  2003-01       Impact factor: 18.112

View more
  22 in total

1.  Neuroanatomical targets of reboxetine and bupropion as revealed by pharmacological magnetic resonance imaging.

Authors:  Sakthivel Sekar; J Van Audekerke; G Vanhoutte; A S Lowe; A M Blamire; A Van der Linden; T Steckler; M Shoaib; Marleen Verhoye
Journal:  Psychopharmacology (Berl)       Date:  2011-05-07       Impact factor: 4.530

2.  Non-pharmacological and pharmacological treatments act on the same brain.

Authors:  Alan C Swann
Journal:  World Psychiatry       Date:  2014-10       Impact factor: 49.548

Review 3.  Progress in Elucidating Biomarkers of Antidepressant Pharmacological Treatment Response: A Systematic Review and Meta-analysis of the Last 15 Years.

Authors:  G Voegeli; M L Cléry-Melin; N Ramoz; P Gorwood
Journal:  Drugs       Date:  2017-12       Impact factor: 9.546

4.  Differential modulation of emotion processing brain regions by noradrenergic and serotonergic antidepressants.

Authors:  Annette Beatrix Brühl; Lutz Jäncke; Uwe Herwig
Journal:  Psychopharmacology (Berl)       Date:  2011-02-26       Impact factor: 4.530

Review 5.  The neuroscience of depression: implications for assessment and intervention.

Authors:  Manpreet K Singh; Ian H Gotlib
Journal:  Behav Res Ther       Date:  2014-09-04

6.  Altered activation in fronto-striatal circuits during sequential processing of conflict in unmedicated adults with obsessive-compulsive disorder.

Authors:  Rachel Marsh; Guillermo Horga; Nidhi Parashar; Zhishun Wang; Bradley S Peterson; H Blair Simpson
Journal:  Biol Psychiatry       Date:  2013-03-13       Impact factor: 13.382

7.  The (Eigen)value of diffusion tensor imaging to investigate depression after traumatic brain injury.

Authors:  Jerome J Maller; Richard H S Thomson; Kerstin Pannek; Stephen E Rose; Neil Bailey; Philip M Lewis; Paul B Fitzgerald
Journal:  Hum Brain Mapp       Date:  2012-09-24       Impact factor: 5.038

Review 8.  Molecular, Functional, and Structural Imaging of Major Depressive Disorder.

Authors:  Kai Zhang; Yunqi Zhu; Yuankai Zhu; Shuang Wu; Hao Liu; Wei Zhang; Caiyun Xu; Hong Zhang; Takuya Hayashi; Mei Tian
Journal:  Neurosci Bull       Date:  2016-05-03       Impact factor: 5.203

9.  Hyperactivation of the cognitive control network in cocaine use disorders during a multisensory Stroop task.

Authors:  Andrew R Mayer; Claire E Wilcox; Terri M Teshiba; Josef M Ling; Zhen Yang
Journal:  Drug Alcohol Depend       Date:  2013-06-02       Impact factor: 4.492

10.  fNIRS Evaluation of Frontal and Temporal Cortex Activation by Verbal Fluency Task and High-Level Cognition Task for Detecting Anxiety and Depression.

Authors:  Xuenan Lang; Dan Wen; Qiqi Li; Qin Yin; Mingyu Wang; Yong Xu
Journal:  Front Psychiatry       Date:  2021-06-29       Impact factor: 4.157

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.